Tectonic Therapeutic Inc [TECX] stock is trading at $16.33, down -1.95%. An important factor to consider is whether the stock is rising or falling in short-term value. The TECX shares have lost -36.45% over the last week, with a monthly amount drifted -22.85%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Tectonic Therapeutic Inc [NASDAQ: TECX] stock has seen the most recent analyst activity on September 03, 2025, when Oppenheimer initiated its Outperform rating and assigned the stock a price target of $80. Previously, Truist started tracking the stock with Buy rating on July 21, 2025, and set its price target to $64. Mizuho started tracking the stock assigning a Outperform rating and suggested a price target of $51 on April 21, 2025. Raymond James initiated its recommendation with a Outperform and recommended $65 as its price target on November 20, 2024. Wells Fargo started tracking with a Overweight rating for this stock on August 22, 2024, and assigned it a price target of $55. In a note dated June 26, 2024, Piper Sandler initiated an Overweight.
Tectonic Therapeutic Inc [TECX] stock has fluctuated between $13.70 and $61.07 over the past year. Tectonic Therapeutic Inc [NASDAQ: TECX] shares were valued at $16.33 at the most recent close of the market.
Analyzing the TECX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.22, Equity is -0.3 and Total Capital is -0.26. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 15.73 points at the first support level, and at 15.14 for the second support level. However, for the 1st resistance point, the stock is sitting at 17.45, and for the 2nd resistance point, it is at 18.58.
Ratios To Look Out For
For context, Tectonic Therapeutic Inc’s Current Ratio is 25.60. On the other hand, the Quick Ratio is 25.60, and the Cash Ratio is 25.3.
Transactions by insiders
Recent insider trading involved SPRINGER TIMOTHY A, Director, that happened on Apr 11 ’25 when 53706.0 shares were purchased. Director, SPRINGER TIMOTHY A completed a deal on Apr 10 ’25 to buy 45858.0 shares. Meanwhile, Director SPRINGER TIMOTHY A bought 21071.0 shares on Apr 09 ’25.
